Literature DB >> 10325659

Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients.

W L van der Graaff1, A P Prins, T M Niers, B A Dijkmans, R A van Lier.   

Abstract

OBJECTIVE: The balance between T cells able to produce interferon gamma (IFN-gamma) (type 1) and interleukin-4 (IL-4) (type 2) is considered to be important in the development of autoimmunity. In this study, we quantitated the percentage of both cell types in synovial fluid (SF) and peripheral blood (PB) of rheumatoid arthritis (RA) patients, non-rheumatoid arthritis patients and healthy controls.
METHODS: After short-term stimulation of synovial mononuclear cells with phorbol ester and ionomycin, cytokine-producing cells were quantitated using an intracellular staining technique and flow cytometric analysis.
RESULTS: Although no significant differences in CD8 + cells were found, significantly higher percentages of IFN-gamma-producing CD4 + (Th 1) and IL-4-producing CD4 + (Th2) cells were found in the peripheral blood of RA patients in comparison with healthy controls. However, the Th1/Th2 ratio was not different between the two groups. Comparative studies between PB and SF showed that in both RA and non-RA patients, percentages of Th1 cells were higher in SF than in PB, while Th2 cells were preferentially found in the PB, resulting in a higher Th1/Th2 ratio in the SF. The Th1/Th2 ratio in the SF correlated with disease activity as estimated by the erythrocyte sedimentation rate.
CONCLUSION: These results are in agreement with the hypothesis that Th1 cells preferentially home to inflamed joints in both RA and non-RA patients, but show that this does not result in an altered Th1/Th2 ratio in the PB of RA patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325659     DOI: 10.1093/rheumatology/38.3.214

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

1.  IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin.

Authors:  S Chapuy-Regaud; L Nogueira; C Clavel; M Sebbag; C Vincent; G Serre
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

2.  Anti-arthritic activity of agnuside mediated through the down-regulation of inflammatory mediators and cytokines.

Authors:  Anjali Pandey; Sarang Bani; Naresh Kumar Satti; Bishan Dutt Gupta; Krishan Avtar Suri
Journal:  Inflamm Res       Date:  2012-01-08       Impact factor: 4.575

3.  Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis.

Authors:  K Holló; T T Glant; M Garzó; A Finnegan; K Mikecz; E Buzás
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

4.  Simultaneous analysis of T cell clonality and cytokine production in rheumatoid arthritis using three-colour flow cytometry.

Authors:  P Bakakos; C Pickard; W M Wong; K R Ayre; J Madden; A J Frew; E Hodges; M I D Cawley; J L Smith
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 5.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

Review 6.  The role of the T cell in autoimmune inflammation.

Authors:  Alla Skapenko; Jan Leipe; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2005-03-16       Impact factor: 5.156

7.  IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).

Authors:  Mariah Chambers; Garrett Kirkpatrick; Michel Evans; Grzegorz Gorski; Sara Foster; Ruth C Borghaei
Journal:  Exp Cell Res       Date:  2013-04-19       Impact factor: 3.905

8.  In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease.

Authors:  R Gerli; O Bistoni; A Russano; S Fiorucci; L Borgato; M E F Cesarotti; C Lunardi
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

9.  Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARgamma activation in human gingival fibroblasts.

Authors:  Denise Stewart; Masoud Javadi; Mariah Chambers; Chad Gunsolly; Grzegorz Gorski; Ruth C Borghaei
Journal:  BMC Mol Biol       Date:  2007-02-23       Impact factor: 2.946

10.  Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors.

Authors:  Agata Kosmaczewska; Lidia Ciszak; Jerzy Swierkot; Aleksandra Szteblich; Katarzyna Kosciow; Irena Frydecka
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.